𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Serum Arginase Activity in Benign Prostatic Hypertrophy and Prostatic Cancer

✍ Scribed by S. Elgün; A. Keskineğe; E. Yilmaz; S. Baltaci; Y. Bedük

Book ID
110248446
Publisher
Springer Netherlands
Year
1999
Tongue
English
Weight
394 KB
Volume
31
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum prostatic acid-phosphatase levels
Serum prostatic acid-phosphatase levels in proved cases of carcinoma or benign hypertrophy of the prostate
✍ Willet F. Whitmore Jr.; Oscar Bodansky; Morton K. Schwartz; Sai Hou Ying; Emerso 📂 Article 📅 1956 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

N 1953 Fishman and Lerner reported a tech-I nique for the determination of that portion of the serum acid phosphatasc that originates from the prostate.9 T h e method is based on the observation of Abul-Fad1 and King that L-tartrate inhibits prostatic acid phosphatase. Fishman and co-workers77 8 sub

Immunohistochemical analysis of β-tubuli
Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy
✍ Ranganathan, Sulabha; Salazar, Hernando; Benetatos, Christopher A.; Hudes, Gary 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

## Background: Beta-tubulin, the intracellular target of several antimicrotubule agents, is encoded by at least six genes and exists as multiple isotypes with tissue-specific expression. previous in vitro studies indicated that tubulin isotype composition may affect polymerization properties, dynam